Virus-Like Particles (VLPS) - Applications In Veterinary Medicine
dc.contributor.author | Saravanan, S. | |
dc.contributor.author | Dinakaran, A. Manicavasaka | |
dc.contributor.author | Kannan, D. | |
dc.contributor.author | Selvaraju, G. | |
dc.contributor.author | Geetha, M. | |
dc.contributor.author | Ganesan, P.I. | |
dc.contributor.author | TANUVAS | |
dc.date.accessioned | 2020-05-30T09:10:28Z | |
dc.date.available | 2020-05-30T09:10:28Z | |
dc.date.issued | 2010-09 | |
dc.description | TNV_LL_Sep2010_5 | en_US |
dc.description.abstract | Vaccines against viral disease have traditionally relied on attenuated virus strains or inactivation of infectious virus. Subunit vaccines based on recombinant proteins can suffer from poor immunogenicity owing to incorrect folding of the target protein or poor presentation to the immune system. A specific class of viral subunit vaccine that mimics the overall structure of virus particles and thus preserves the native antigenic conformation of the immunogenic proteins. are called virus-like particles (VLPs) which have been produced for a wide range of taxonomically and structurally distinct viruses, and have unique advantages in terms of safety and immunogenlcity over previous approaches. | en_US |
dc.identifier.uri | http://krishikosh.egranth.ac.in/handle/1/5810146729 | |
dc.keywords | Veterinary Science | en_US |
dc.language.iso | en_US | en_US |
dc.pages | 5 | en_US |
dc.title | Virus-Like Particles (VLPS) - Applications In Veterinary Medicine | en_US |
dc.type | Article | en_US |